Nuklearmedizin 2006; 45(06): N64-N66
DOI: 10.1055/s-0038-1625107
Originalarbeiten – Original Articles
Schattauer GmbH

Necrobiotic panniculitis due to repeated insulin injection: a rare cause of a false positive somatostatin receptor scintigraphy

G. Zettinig
1   Department of Nuclear Medicine
,
F. Wrba
2   Department of Pathology
,
F. Trautinger
3   Department of Dermatology
,
P. Peloschek
4   Department of Radiology
,
A. Luger
5   Department of Internal Medicine III, Medical University of Vienna, Austria
› Author Affiliations
Further Information

Publication History

Received: 09 March 2006

in revised form: 04 September 2006

Publication Date:
11 January 2018 (online)

 

 
  • References

  • 1 Balon HR, Goldsmith SJ, Siegel BA. et al. Procedure guideline for somatostatin receptor scintigraphy with 111In-pentetreotide. J Nucl Med 2001; 42: 1134-8.
  • 2 Degirmenci B, Bekis R, Sen M. et al. Indium-111 octreotide uptake in the surgical scar. Nuklearmedizin 1999; 38: 306-8.
  • 3 Forster GJ, Krummenauer F, Nickel O. et al. Somatostatin- receptor scintigraphy in Graves’ disease: reproducibility and variance of orbital activity. Cancer Biother Radiopharm 2000; 15: 517-25.
  • 4 Kainberger F, Kurtaran A, Kienast O. et al. Hybrid imaging for endocrine diseases: new perspectives. Wien Klin Wochenschr 2003; 115 (Suppl. 02) 87-90.
  • 5 Ozer S, Dobrozemsky G, Kienast O. et al. Value of combined XCT/SPECT technology for avoiding false positive planar 123I-MIBG scintigraphy. Nuklearmedizin 2004; 43: 164-70.
  • 6 Reubi JC, Kvols E, Krenning E. et al. Distribution of somatostatin receptors in normal and tumor tissue. Metabolism 1990; 9: 78-81.
  • 7 Virgolini I, Traub T, Novotny C. et al. Experience with indium-111 and yttrium-90-labeled somatostatin analogs. Curr Pharm Des 2002; 8: 1781-807.